01Jul/13

Transasia Bio-Medicals Ltd. organises blood donation drive on the occasion of … – India PRwire (press release)


India PRwire (press release)

Transasia Bio-Medicals Ltd. organises blood donation drive on the occasion of
India PRwire (press release)
India’s leading IVD Company, Transasia Bio-Medicals Ltd. is committed to global healthcare and our efforts are not only restricted to offering world class solutions. We have always strived to contribute to the society in all the ways we can. World

01Jul/13

Dr. Reddy's partners with leading oncologists in furthering awareness on Lung … – India PRwire (press release)


Economic Times

Dr. Reddy’s partners with leading oncologists in furthering awareness on Lung
India PRwire (press release)
Dr. Reddy’s Oncology business in India aims at bringing in a SEA (Science, Education and Accessibility) change in the treatment of Cancer in India. Our aim is to facilitate and ensure that our treating physicians get the best information on the latest 
Dr Reddy’s Laboratories launches online repositories on lung and breast cancerEconomic Times
Dr Reddy’s launches online repositories on lung, breast cancersHindu Business Line
Dr Reddy ties up with Shvaas and IBCR for lung & breast cancer awareness in pharmabiz.com
Business Standard
all 77 news articles »
01Jul/13

Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment … – The Herald | HeraldOnline.com

Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment
The Herald | HeraldOnline.com
The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares PIXUVRI-rituximab to gemcitabine-rituximab in patients who